Overall Status

Recruiting (30)

Completed (16)

Active, not recruiting (10)

Terminated (8)

Not yet recruiting (4)

Withdrawn (4)

Unknown status (3)

Approved for marketing (1)

No longer available (1)

Phase

phase 2 (37)

phase 1/phase 2 (9)

phase 3 (5)

n/a (2)

phase 1 (2)

phase 2/phase 3 (1)

phase 4 (1)

Study Documents

Intervention Type

drug (64)

other (9)

biological (6)

procedure (3)

genetic (2)

behavioral (1)

combination product (1)

device (1)

diagnostic test (1)

Funder Type

Other (52)

Industry (23)

NIH (2)

Study Type

Interventional (57)

Observational (16)

Expanded Access (2)

Observational [Patient Registry] (2)

Ponatinib

Showing 76 - 77 of 77

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Myeloid Leukemia Trial in Worldwide (ponatinib, imatinib (Gleevec/ Glivec))

Terminated

Has Results

Chronic Myeloid Leukemia

ponatinib
imatinib (Gleevec/ Glivec)

Burbank, California
+169 more

Nov 5, 2014

Philadelphia Chromosome Positive (Ph+) Leukemias, Chronic Myeloid Leukemia Trial in Portland (Ponatinib)

No longer available

Philadelphia Chromosome Positive (Ph+) Leukemias
Chronic Myeloid Leukemia

Ponatinib

Portland, Oregon

OHSU Knight Cancer Institute

Mar 13, 2013